Biovotec Obtains Additional Funding And RecognitionCEO Ralf Schmidt raised another 15 million NOK in new capital and now he is asked to present Biovotec to the British health authorities.
CEO Ralf Schmidt raised another 15 million NOK in new capital and now he is asked to present Biovotec to the British health authorities.
